Your browser doesn't support javascript.
loading
Ixazomib, lenalidomide, and dexamethasone is effective and well tolerated in multiply relapsed (≥2nd relapse) refractory myeloma: a multicenter real world UK experience.
Maouche, Nadjoua; Kishore, Bhuvan; Jenner, Matthew W; Boyd, Kevin; Bhatti, Zara; Bird, Sarah Anne; Chander, Gurvin; Robinson, Rebecca; Vallance, Grant D; Offer, Mark; Kothari, Jaimal; Peniket, Andy; Aitchison, Robin; Dungarwalla, Moez; Collings, Freya; Bygrave, Ceri; Ramasamy, Karthik.
Afiliación
  • Maouche N; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Kishore B; Department of Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Jenner MW; Department of Haematology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Boyd K; Department of Haemato-Oncology, The Royal Marsden Hospital, Sutton, UK.
  • Bhatti Z; Department of Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Bird SA; Department of Haemato-Oncology, The Royal Marsden Hospital, Sutton, UK.
  • Chander G; Department of Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Robinson R; Department of Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Vallance GD; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Offer M; Department of Haematology, Frimley Health NHS Foundation Trust, Frimley, UK.
  • Kothari J; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Peniket A; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Aitchison R; Department of Haematology, Buckinghamshire Healthcare NHS Trust, Bucks, UK.
  • Dungarwalla M; Department of Haematology, Milton Keynes University Hospital NHS Foundation Trust, Milton Keynes, UK.
  • Collings F; Department of Haematology, Great Western Hospitals NHS Foundation Trust, Swindon, UK.
  • Bygrave C; Department of Haematology, University Hospital of Wales, Cardiff, UK.
  • Ramasamy K; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Leuk Lymphoma ; 62(6): 1396-1404, 2021 06.
Article en En | MEDLINE | ID: mdl-33356703
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Clinical_trials Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Clinical_trials Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido